돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 133587생성일: 2026년 10월 25일

Hippuric Acid → 4-[(N-benzoylglycyl)amino]methyl-1-(4-chlorobenzyl)piperidine

https://huagongshe.com/reaction/133587

반응식

참여 물질

역할이름HCID투입량
반응물Hippuric AcidHCID 464—
반응물TriethylamineHCID 8471—
반응물1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 15908—
반응물1-HydroxybenzotriazoleHCID 75771—
반응물{[1-(4-Chlorobenzyl)piperidin-4-yl]methyl}amineHCID 18426145—
용매DichloromethaneHCID 6344—
생성물4-[(N-benzoylglycyl)amino]methyl-1-(4-chlorobenzyl)piperidineHCID 18426192125%

반응 조건

온도25 °C

반응 단계

Hippuric acid (38 mg, 0.21 mmol), EDCI (48 mg, 0.24 mmol), HOBt (31 mg, 0.23 mmol) and triethylamine (38 μL, 0.27 mmol) were added to a dichloromethane (1 mL) solution of 4-(aminomethyl)-1-(4-chlorobenzyl)piperidine (50 mg, 0.21 mmol). The resulting reaction mixture was shaken at 25° C. for 16 hours, then diluted with 1 mL of dichloromethane, washed with a 2 M aqueous solution of NaOH (0.75 mL×2), dried (over MgSO4), concentrated and purified by chromatography (SiO2, 6-8% methanol/dichloromethane) to thereby afford 4-[(N-benzoylglycyl)amino]methyl-1-(4-chlorobenzyl)piperidine (Compd. No. 458). The resulting compound was treated with TFA to provide a TFA salt (105 mg, 97%). The purity was determined by RPLC/MS (85%). ESI/MS m/e 400 (M++H, C22H26ClN3O2).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07390830B1
출처 데이터셋uspto-grants-2008_06
ORD IDord-417eb02fb1774d4c84ec57fe787b3474
출처 메모uspto-grants-2008_06